SomnoMed: Interim result 2014

Unit sales and revenues are growing strongly at SomnoMed, although higher profits will have to wait as the company continues to invest.

Last month we introduced mandibular splint manufacturer SomnoMed (try saying that three times quickly) to our buy list in SomnoMed: A future mini-ResMed on 5 Feb 14 (Speculative Buy – $1.33).

Mandibular splits look like a oversized mouthguard and prop the lower jaw forward slightly, to keep the airway open and prevent people suffering from obstructive sleep apnea (OSA) while they sleep.

{{content.question}}

{{ twilioFailed ? 'SMS Code Failed to Send…' : 'SMS Code Sent…' }}

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

We cannot send you a code via SMS to {{user.DayPhone}}

If you didn't receive SMS code please

SMS code cannot be sent due to: {{ twilioStatus }}

Please select one of the options below:

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa
Mastercard

The email address you entered is registered with InvestSMART.

Please login or select "Don't know password"

Please untick this box when using a public or shared device


Register as a new member

(using a different email)

Related Articles